SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeen Regulatory News (SEEN)

Share Price Information for Seeen (SEEN)

Share Price is delayed by 15 minutes
Get Live Data
4.50    0.00 (0.00%)
Bid:
4.00
Ask:
5.00
Spread: 1.00 (25.00%)
Market Cap: £6.39m
SEEN Live PriceLast checked at - London Stock Exchange

Intraday Seeen Share Chart

Director dealing

30 Apr 2025 07:00

RNS Number : 7109G
SEEEN PLC
30 April 2025
 

 

30 April 2025

 

 

SEEEN plc

("SEEEN", the "Group" or the "Company")

 

Director dealing

 

SEEEN plc (AIM: SEEN), the global media and technology platform that delivers Key Video Moments to drive Video Commerce and transform its clients' video profitability, was advised on 29 April 2025 of a transfer of 600,000 ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") held by Adrian Hargrave, Chief Executive Officer, from his personal holding to his SIPP. The transfer was effected by an on market sale and purchase, both at a price of 6p pence per Ordinary Share, on 29 April 2025. Following this, Mr Hargrave's total beneficial interest in Ordinary Shares is unchanged at 2,295,265 Ordinary Shares, equivalent to 1.88% of the Company's issued share capital.

 

Further details of the above share dealing are set out in the FCA notification made in accordance with the requirements of the UK Market Abuse Regulation, which is appended below.

 

 

For further information please contact:

SEEEN plc

Tel: +44 (0)7775 701 838

Adrian Hargrave, Chief Executive Officer

Dowgate Capital Limited - Joint Broker

Tel: +44 (0)20 3903 7715

Stephen Norcross

Capital Plus Partners Limited - Joint Broker

Tel: +44 (0)20 3821 6167

Jonathan Critchley

 

Allenby Capital Limited - Nominated Adviser

Tel: +44 (0)20 3328 5656

Alex Brearley / Lauren Wright (Corporate Finance)

focusIR - Investor Relations

Tel: +44 (0)20 4570 2234

Paul Cornelius / Kat Perez

email: seeen@focusir.com

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

1. Adrian Hargrave (personal holding)

2. Adrian Hargrave (SIPP)

2

Reason for the notification

a)

Position/status:

Director, Chief Executive Officer

b)

Initial notification/Amendment:

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

SEEEN plc

b)

LEI:

213800RQVRMW2KRORN22

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary Shares

 

GB00BK6SHS41

b)

Nature of the transaction:

1. Sale of of Ordinary Shares from his personal holding

2. Purchase of Ordinary Shares into SIPP

c)

Price(s) and volume(s):

 

 

Price(s)

Volume(s)

1.

6 pence

600,000

2.

6 pence

600,000

d)

Aggregated information:

·Aggregated volume:

·Price:

 

As above.

e)

Date of the transaction:

29 April 2025

f)

Place of the transaction:

 London Stock Exchange (AIM)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHVKLFLEZLFBBQ
Date   Source Headline
24th Jun 20243:23 pmRNSHolding(s) in Company
20th Jun 20244:22 pmRNSHolding(s) in Company
17th Jun 202412:55 pmRNSResult of General Meeting and Total Voting Rights
7th Jun 202412:23 pmRNSHolding(s) in Company
5th Jun 20248:30 amRNSAdmission of First Fundraise Shares
31st May 20247:00 amRNSPlacing and Subscription and other matters
1st Mar 20247:00 amRNSPartnership with the American 7s Football League
2nd Feb 20247:00 amRNSDirector dealings
1st Feb 20247:00 amRNSTrading Update and Board Change
18th Jan 20247:00 amRNSPartnership with the London Broncos
29th Sep 20237:00 amRNSInterim Results
26th Sep 202311:57 amRNSHolding(s) in Company
6th Sep 20237:00 amRNSTechnology Day
24th Aug 20237:00 amRNSDirector dealing
26th Jul 202312:23 pmRNSResult of AGM
26th Jul 20237:00 amRNSLaunch of CreatorSuite 2.0
30th Jun 20237:00 amRNSResults for the year ended 31 December 2022
7th Jun 20237:00 amRNSAttendance at UK Investor Show
18th May 20237:00 amRNSAppointment of Non-Executive Director and CFO
6th Feb 20237:00 amRNSTrading Update, Customer Win and Board Change
11th Jan 202312:22 pmRNSHolding(s) in Company
4th Jan 20231:15 pmRNSHolding(s) in Company
30th Dec 20221:00 pmRNSTotal Voting Rights
28th Dec 20227:00 amRNSHolding(s) in Company
28th Dec 20227:00 amRNSHolding(s) in Company
23rd Dec 20229:44 amRNSResult of GM and Open Offer
7th Dec 20226:25 pmRNSFundraise and other matters
7th Dec 20226:22 pmRNSAppointment of Nominated Adviser and Joint Broker
8th Nov 20225:27 pmRNSHolding(s) in Company
28th Oct 20225:13 pmRNSHolding(s) in Company
29th Sep 20227:00 amRNSInterim Results
26th Aug 20225:07 pmRNSHolding(s) in Company
25th Aug 20227:00 amRNSHolding(s) in Company
17th Aug 20227:00 amRNSDirector/PDMR Shareholding
28th Jul 20224:59 pmRNSResult of AGM
11th Jul 20227:01 amRNSCustomer Win - Daily Mail
11th Jul 20227:00 amRNSCEO Appointment
6th Jul 20227:00 amRNSCustomer Wins
30th Jun 20227:00 amRNSFinal Results and Notice of AGM
31st May 20227:00 amRNSDirector Shareholding and Notice of Results
31st May 20227:00 amRNSHolding(s) in Company
27th May 20227:00 amRNSBoard Appointment Confirmation
25th Apr 20224:41 pmRNSSecond Price Monitoring Extn
25th Apr 20224:36 pmRNSPrice Monitoring Extension
7th Apr 20227:00 amRNSContract Wins
16th Mar 20227:00 amRNSDirector Changes, Business Update
23rd Feb 20227:00 amRNSStrategic Partnership with Kinetiq, Inc
3rd Feb 20227:00 amRNSTrading Update
27th Jan 20227:00 amRNSContract Wins and Notice of Trading Update
2nd Dec 20217:00 amRNSContract Wins and 3Q Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.